BioMedomics Wins the Triangle Global Health Consortium’s 2017 Breakthrough Innovation Award!

BioMedomics is excited to announce that we were selected as the winner of the Triangle Global Health Consortium’s 2017 Breakthrough Innovation Award in recognition of our innovative rapid point-of-care diagnostics line, which has provided unprecedented ease of use, efficiency and accuracy for the diagnosis of lethal and widespread hemoglobin disorders.

We are very honored to receive this award which is truly a testament of our dedication to help save lives around the globe by improving the quality and speed of our point-of-care diagnostics.

BioMedomics, Inc. will be honored at the Triangle Global Health Awards Ceremony at the Top of Hill at Chapel Hill on Tuesday, May 2nd 2017, where we will celebrate the local leaders in global health. A full list of winners and the official award announcement from the Triangle Global Health Consortium can be found here.

About BioMedomics:

BioMedomics is a ISO certified POC diagnostics company focused on developing unique rapid POC tests for blood disorders. We have 4 products that have already received CE Mark approval: Our leading product, Sickle SCAN, for the detection of Sickle Cell Disease and Sickle Cell Trait, has been sold into more than 20 countries; other products are alpha-Thal SCAN, and Hemo SCAN. we are also launching a novel POC quantitative test for hemoglobin S (HbS) which is used in the treatment of SCD. Additionally, quantitative POC tests for TSH, testosterone, vitamin D and troponin based on our patented high sensitivity Time Resolved diagnostics platform and a rapid POC test for beta-thalassemia, are also und

er development.

About the Triangle Global Health Awards:

Each year the Triangle Global Health Consortium recognizes a few of the many individuals, organizations and corporations making a difference in the lives of people around the world. Those making outstanding contributions in improving health around the world and here in North Carolina will be recognized in each of our 4 award categories: Triangle Global Health Champion, Ward Cates Emerging Leader Award, Corporate Impact Award, and the Breakthrough Innovation Award.

About the Triangle Global Health Consortium:

The Triangle Global Health Consortium (TGHC) is a nonprofit member organization representing institutions and individuals from the pharmaceutical and biotechnology industry, the international health development nongovernmental organization community, and academia. TGHC includes 18 institutional members and numerous individual members, representing some of the best and brightest in the field of global health.

Featured Posts
Search By Tags
No tags yet.
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square